Merck joins the list of drug makers agreeing to freeze or lower some prices
(By Ed Silverman for STAT) As political pressure on the pharmaceutical industry builds, Merck has become the latest big drug
Read More
New proposal would remove safe-harbor protections for drug rebates
The Office of Management and Budget was sent a proposed regulation that would make changes to federal safe harbor protections
Read MoreStakeholders want CMS to use analytics to stop fraudulent payments
(By Julie Spitzer for Becker’s Hospital Review) In a July 17 House Ways and Means Committee hearing, government officials heard
Read MoreMedicare’s bundled-payment system did not reduce costs
In a new study led by Washington University School of Medicine in St. Louis found Medicare’s bundled-payment system did not
Read MoreFDA’s Gottlieb slams drug makers for stalling release of biosimilars
(By Erin Mershon for STAT) WASHINGTON — Food and Drug Administration Commissioner Scott Gottlieb on Wednesday accused drug makers who
Read MoreNovartis hits the brakes on price hikes as political pressure builds
(By Ed Silverman for STAT) In response to the heated political rhetoric over the cost of prescription drugs, Novartis has decided not
Read MoreWhat is a Medigap supplement plan?
What is a Medigap supplement plan and what does it cover? In Philip Moeller’s “Ask Phil” column, he gives a
Read MoreHurricane Maria Still Taking A Toll On Puerto Rico’s Seniors
(By Sarah Varney for Kaiser Health News in collaboration with PBS NewsHour) The question of who will care for Puerto
Read MoreGOP chairman, HHS’ Azar in talks to restart ACA’s $10.4B risk-adjustment payments
(By Emily Rappleye for Becker’s Hospital Review) Rep. Kevin Brady, R-Texas, chairman of the House Ways and Means Committee, was
Read MoreMedicaid Under The Influence: How Drugmakers Sway Medication Options For Patients
(By Liz Essley Whyte, Joe Yerardi and Alison Kodjak for NPR and The Center for Public Integrity) Eight months pregnant,
Read More